GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
GLAXO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
GlaxoSmithKline Pharmaceuticals has informed the stock exchange that the trading window for dealing in the company's shares has been closed for designated persons and their immediate relatives. This is a routine compliance measure required under SEBI's Insider Trading Regulations. Trading windows are typically shut before the announcement of financial results, board meetings, or other material events to prevent insider trading. The window will reopen after 48 hours of the relevant results or event being made public.
This is a standard regulatory compliance disclosure with no material impact on shareholders or the stock price. It simply means insiders cannot trade in the stock during a specified period, usually around earnings announcements.